Sabri O - Search Results

1

Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses.

Meyer PT, Schreckenberger M, Spetzger U, Meyer GF, Sabri O, Setani KS, Zeggel T, Buell U. Meyer PT, et al. Among authors: sabri o. Eur J Nucl Med. 2001 Feb;28(2):165-74. doi: 10.1007/s002590000428. Eur J Nucl Med. 2001. PMID: 11303886

2

[Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings].

Sabri O, Hellwig D, Kaiser HJ, Doherty C, Schneider R, Mull M, Willmes von Hinckeldey KW, Büll U, Thron A, Ringelstein EB. Sabri O, et al. Nuklearmedizin. 1995 Apr;34(2):50-6. Nuklearmedizin. 1995. PMID: 7761273 Clinical Trial. German.

3

A method of correlating and merging cerebral morphology and function by a special head holder.

Kaiser HJ, Sabri O, Wagenknecht G, Lege B, Hellwig D, Büll U. Kaiser HJ, et al. Among authors: sabri o. Nuklearmedizin. 1994 Jun;33(3):123-6. Nuklearmedizin. 1994. PMID: 8090627

4

[Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI].

Büll U, Foroutan Y, Hellwig D, Kaiser HJ, Schulz G, Sabri O, Schreckenberger M, vom Dahl J. Büll U, et al. Among authors: sabri o. Nuklearmedizin. 1995 Dec;34(6):223-8. Nuklearmedizin. 1995. PMID: 8596738 German.

5

Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET.

Cremerius U, Bares R, Weis J, Sabri O, Mull M, Schröder JM, Gilsbach JM, Buell U. Cremerius U, et al. Among authors: sabri o. J Nucl Med. 1997 Jan;38(1):26-30. J Nucl Med. 1997. PMID: 8998144 Free article.

6

Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPET.

Schulz G, von Dahl J, Kaiser HJ, Koch KC, Sabri O, Banneitz L, Cremerius U, Buell U. Schulz G, et al. Among authors: sabri o. Nucl Med Commun. 1996 Dec;17(12):1057-64. doi: 10.1097/00006231-199612000-00010. Nucl Med Commun. 1996. PMID: 9004303

7

Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics.

Sabri O, Erkwoh R, Schreckenberger M, Cremerius U, Schulz G, Dickmann C, Kaiser HJ, Steinmeyer EM, Sass H, Buell U. Sabri O, et al. J Nucl Med. 1997 Feb;38(2):181-8. J Nucl Med. 1997. PMID: 9025731 Free article.

8

Comparison of PET, SPET, neuropsychological and morphological findings in vascular dementia.

Sabri O, Schneider R, Buell U. Sabri O, et al. Eur J Nucl Med. 1997 Mar;24(3):348-9. doi: 10.1007/BF01728777. Eur J Nucl Med. 1997. PMID: 9143477 No abstract available.

9

Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.

Zimny M, Bares R, Fass J, Adam G, Cremerius U, Dohmen B, Klever P, Sabri O, Schumpelick V, Buell U. Zimny M, et al. Among authors: sabri o. Eur J Nucl Med. 1997 Jun;24(6):678-82. doi: 10.1007/BF00841409. Eur J Nucl Med. 1997. PMID: 9169578

10

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics.

Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U. Sabri O, et al. Lancet. 1997 Jun 14;349(9067):1735-9. doi: 10.1016/S0140-6736(96)08380-8. Lancet. 1997. PMID: 9193384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters